iBio Inc (IBIO)
1.85
+0.14
(+8.19%)
USD |
NYAM |
May 01, 16:00
1.90
+0.05
(+2.70%)
After-Hours: 20:00
iBio Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.05M |
| June 30, 2023 | -0.006M |
| March 31, 2023 | 8.241M |
| December 31, 2022 | -1.255M |
| September 30, 2022 | 0.029M |
| June 30, 2022 | 0.477M |
| March 31, 2022 | 0.517M |
| December 31, 2021 | -0.972M |
| September 30, 2021 | -5.149M |
| June 30, 2021 | -2.908M |
| March 31, 2021 | -4.014M |
| December 31, 2020 | -12.96M |
| September 30, 2020 | -6.60M |
| June 30, 2020 | -0.82M |
| March 31, 2020 | -0.096M |
| December 31, 2019 | -0.208M |
| September 30, 2019 | -0.03M |
| June 30, 2019 | -0.173M |
| March 31, 2019 | -0.139M |
| December 31, 2018 | -0.389M |
| September 30, 2018 | -0.289M |
| June 30, 2018 | -0.282M |
| March 31, 2018 | -0.485M |
| December 31, 2017 | -0.201M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.111M |
| June 30, 2017 | -0.525M |
| March 31, 2017 | -0.303M |
| December 31, 2016 | -0.163M |
| September 30, 2016 | -0.602M |
| June 30, 2016 | -0.06M |
| March 31, 2016 | -0.003M |
| December 31, 2015 | 0.013M |
| September 30, 2015 | -0.018M |
| June 30, 2015 | -0.063M |
| March 31, 2015 | -0.052M |
| December 31, 2014 | -0.069M |
| September 30, 2014 | -0.031M |
| June 30, 2014 | -0.059M |
| March 31, 2014 | -0.118M |
| December 31, 2013 | -0.023M |
| September 30, 2013 | -0.059M |
| June 30, 2013 | -0.037M |
| March 31, 2013 | -0.047M |
| December 31, 2012 | -0.053M |
| September 30, 2012 | -0.058M |
| June 30, 2012 | -0.0594M |
| March 31, 2012 | -0.0635M |
| December 31, 2011 | -0.0297M |
| September 30, 2011 | -0.0923M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-12.96M
Minimum
Dec 2020
8.241M
Maximum
Mar 2023
-1.362M
Average
-0.173M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Lixte Biotechnology Holdings Inc | -- |
| PAVmed Inc | -0.183M |
| Avalo Therapeutics Inc | 0.00 |
| Imunon Inc | -3.304M |
| Ocugen Inc | -2.722M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.706M |
| Cash from Financing (Quarterly) | 4.005M |
| Free Cash Flow | -18.89M |
| Free Cash Flow Per Share (Quarterly) | -2.536 |
| Free Cash Flow Yield | -892.9% |